Clinical Trial Update: Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Maridebart Cafraglutide versus placebo for adults with obesity and obstructive sleep apnea on positive airway pressure thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea

Drugs mentioned

• Maridebart Cafraglutide

Snippet

Sponsor: Amgen | Conditions: Obesity, Obstructive Sleep Apnea | Phase 3 | Status: RECRUITING